Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Gastroenterología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Reclutando
ClinicalTrials.gov
Physiological Umbilical Cord Clamping in Patients With Congenital Diaphragmatic Hernia. Clinical Trial
INTERVENTIONAL
Inicio: 14 de jun de 2022
ID: NCT06408376
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2b Randomized, Double-Blind, Placebo-controlled, Multicenter Study Evaluating Safety and Efficacy of EDP-305 in Subjects With Liver Biopsy Proven Non-alcoholic Steatohepatitis (NASH) (ARGON-2)
INTERVENTIONAL
Inicio: 27 de ene de 2020
ID: NCT04378010
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects With Ulcerative Colitis
INTERVENTIONAL
Inicio: 28 de ago de 2018
ID: NCT03398135
Completado
Fase 3
ClinicalTrials.gov
A Comparative Study of the Antiviral Efficacy and Safety of Entecavir (ETV) Versus Placebo in Pediatric Subjects With Chronic Hepatitis B Virus (HBV) Infection Who Are HBeAg-Positive
INTERVENTIONAL
Inicio: 30 de jun de 2010
ID: NCT01079806
Activo, no recluta
ClinicalTrials.gov
Prospective Real World Study Of Upadacitinib in Ulcerative Colitis (PROFUNDUS)
OBSERVATIONAL
Inicio: 15 de ago de 2022
ID: NCT05494606
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2 Long-Term Extension (LTE) Study to Evaluate The Safety and Efficacy of Efavaleukin Alfa in Subjects With Moderately to Severely Active Ulcerative Colitis
INTERVENTIONAL
Inicio: 28 de abr de 2023
ID: NCT05672199
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Interventional, Randomized, Multicenter, Open-Label Study of Ripretinib vs Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor (GIST) After Treatment With Imatinib
INTERVENTIONAL
Inicio: 8 de feb de 2019
ID: NCT03673501
Completado
Fase 3
ClinicalTrials.gov
Phase III, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy (Induction of Remission) and Safety of Etrolizumab Compared With Adalimumab and Placebo in Patients With Moderate to Severe Ulcerative Colitis Who Are Naive to TNF Inhibitors
INTERVENTIONAL
Inicio: 14 de nov de 2014
ID: NCT02171429
Reclutando
Fase 2
ClinicalTrials.gov
A Prospective, Multi-Centre Study (B-Sure) to Evaluate Long-Term Durability of Treatment Response in Chronic Hepatitis B Participants With and Without Nucleos(t)Ide Therapy Who Have Participated in a Previous Bepirovirsen Treatment Study
INTERVENTIONAL
Inicio: 14 de dic de 2021
ID: NCT04954859
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Open-Label Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
INTERVENTIONAL
Inicio: 24 de ago de 2018
ID: NCT03467958
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
INTERVENTIONAL
Inicio: 1 de dic de 2010
ID: NCT01170663
Completado
Fase 3
ClinicalTrials.gov
Open-label, Randomized, Controlled, Multicenter Phase III Study Investigating Cetuximab in Combination With Capecitabine (Xeloda, X) and Cisplatin (P) Versus XP Alone as First-line Treatment for Subjects With Advanced Gastric Adenocarcinoma Including Adenocarcinoma of the Gastroesophageal Junction
INTERVENTIONAL
Inicio: 1 de jun de 2008
ID: NCT00678535
Completado
Fase 3
ClinicalTrials.gov
Phase III in Partial and Null Responders
INTERVENTIONAL
Inicio: 1 de feb de 2012
ID: NCT01485991
Completado
ClinicalTrials.gov
Characteristics and Management of Acute Kidney Injury in Hospitalized Patients With Cirrhosis: a Multicenter Intercontinental Observational Prospective Study: The International Club of Ascites GLOBAL AKI Project
OBSERVATIONAL
Inicio: 1 de jul de 2022
ID: NCT05387811
Reclutando
ClinicalTrials.gov
SMASH: Study to Evaluate the Clinical Efficacy of an Extensively Hydrolysed Infant Formula With Synbiotics and a Human Milk Oligosaccharide (HMO) in Infants With Cow's Milk Protein Allergy (CMPA)
OBSERVATIONAL
Inicio: 7 de feb de 2025
ID: NCT07342621
Completado
Fase 2
ClinicalTrials.gov
A Randomized Controlled Trial of Dietary Supplementation With Bifidobacterium Infantis NLS Super Strain Among Celiac Disease Patients on a Gluten-free Diet With Persistent Gastrointestinal Symptoms
INTERVENTIONAL
Inicio: 21 de jul de 2017
ID: NCT03271138
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
INTERVENTIONAL
Inicio: 17 de jul de 2018
ID: NCT03566823
Completado
Fase 3
ClinicalTrials.gov
NEWBORN VENTILATION IN THE DELIVERY ROOM: CAN IT BE IMPROVED WITH A T-PIECE RESUSCITATOR? Multicenter Cross-over Cluster Randomized Controlled Trial
INTERVENTIONAL
Inicio: 1 de dic de 2009
ID: NCT00443118
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Global, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Once-daily Oral Avatrombopag for the Treatment of Adults With Thrombocytopenia Associated With Liver Disease Prior to an Elective Procedure
INTERVENTIONAL
Inicio: 1 de feb de 2014
ID: NCT01972529
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Multinational, Open-Label Extension Study to Evaluate the Long-Term Safety of CC-93538 in Adult and Adolescent Subjects With Eosinophilic Esophagitis
INTERVENTIONAL
Inicio: 14 de sept de 2021
ID: NCT04991935
Anterior
1
...
27
28
29
...
434
Siguiente
Filtros